For more information, contact:
Lynda Ruffini, Chair, VCA Health Committee
Pam Hidaka, Chair, VCA Breed Improvement
See also the VCA Welfare Foundation
In the fall of 2014, with funding from the AKC Canine Health Foundation (AKC CHF), Dr. Ned Patterson and his team at the University of Minnesota launched Phase 3 of the Epilepsy Research Initiative to identify multiple markers for the disease, concentrating on both the Vizsla and the Australian Shepherd. To insure the success of this research, Dr. Patterson’s team needs as many affected samples from seizing dogs as possible, including related family members. They also need samples from unaffecteds (or controls) who are 8 years or older. FMI about sample submission and participation in the Epilepsy Research Initiative
, please contact Katie Minor at email@example.com
. All submission information will be kept confidential.
The first Vizsla-specific research of its kind, this study will collect DNA blood samples from both affected Vizslas (those actually diagnosed with MCT) and non-affected controls. Control dogs must be 8 years or older and proven to be free of the disease. To participate in the study, please contact Susan Garrison at firstname.lastname@example.org
Launched in October 2011, The Cornell University Hospital for Animals now offers genetics counseling for Vizsla breeders who would like to understand better how medical genetics inform breeding decisions. For those breeders who are participating in the Vizsla MCT Study (see above), this is a perfect opportunity for collaboration. To learn more, please contact Dr Marta Castelhano DVM at email@example.com
with the Cornell University Pediatrics and Medical Genetics Service.
Vizsla Breed Health Survey, sponsored in 2008 by the VCA WF
The 2008 Vizsla Health Survey was sponsored and funded by the Vizsla Club of America Welfare Foundation, Inc. The purpose of this health survey was to inform scientific research that to help us identify and better understand the health issues present in the Vizsla breed today. This was an anonymous survey, and all data collected was kept confidential.
The Vizsla Club of America calls for breeding stock to be radiographed and specifies that no dog or bitch with the slightest evidence of hip dysplasia be used for breeding purposes. In keeping with this resolution, the Vizsla News will not accept ads from any Vizsla as breeding stock that does not have an OFA number. Ads for litters of puppies will not be accepted unless the sire and dam had OFA numbers at the time of breeding. Complete OFA numbers must be sent in with each ad request and will be printed in full. OFA requirements do not apply to dogs appearing in news articles.
Instructions for OFA diagnosis may be obtained for a fee from the:
Orthopedic Foundation for Animals
2300 E. Nifong Blvd.
Columbia, MO 65201-3856
Fast facts about PennHip research
For more information about PennHip testing and expenses:
ANTECH Imaging Services
17672-B Cowan Avenue
Irvine, CA 92614 USA
The officers and board of directors of The Vizsla Club of America, Inc., in cognizance of their respective responsibilities to protect the breed and foster its development, do hereby condemn the breeding of dogs with serious genetic defects including: epilepsy, PRA (Progressive Retinal Atrophy), Von Willebrand's Disease, entropian and cranial muscular atrophy. (Please note: tests for PRA and Von Willebrand's Disease are available. Please discuss this with your veterinarian.)
The officers and board of directors of The Vizsla Club of America, Inc., in cognizance of their respective responsibilities to protect the breed and foster its development, do hereby condemn crossbreeding of purebred Vizslas and falsification of registration documents. All person's following the Vizsla fancy are enjoined to subscribe to this ethic in the best interest of the breed.